ID   JMUi001-A-4
AC   CVCL_D6KN
SY   JUP-KO; UKWCHFi002-A-4
DR   hPSCreg; JMUi001-A-4
DR   Wikidata; Q127382400
RX   PubMed=37995437;
CC   From: Comprehensive Heart Failure Center, University Clinic Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 6207; JUP.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C206112; Naxos disease
DI   ORDO; Orphanet_34217; Naxos disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZL58 ! JMUi001-A
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
RX   PubMed=37995437; DOI=10.1016/j.scr.2023.103240;
RA   Walz K., Janz A., Klopocki E., Gerull B.;
RT   "Generation of a CRISPR/Cas9-edited plakoglobin (JUP) knock-out
RT   (JMUi001-A-4) iPSC line to model the cardiac phenotype of
RT   arrhythmogenic cardiomyopathy.";
RL   Stem Cell Res. 73:103240-103240(2023).
//